Related Experiment Videos
Prophylactic antiviral therapy in CMV high-risk liver transplant recipients
J M Rabkin1, H R Rosen, C L Corless
1Department of Surgery, Section of Liver Transplantation, Oregon Health Sciences University and Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
Transplantation Proceedings
|March 27, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Urgent Liver Transplantation for Dietary Supplements: An Under-Recognized Problem.
Transplantation proceedings·2017
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
The Signature Program: Bringing the Protocol to the Patient.
Clinical pharmacology and therapeutics·2015
A Modified Approach to Dual Kidney Transplantation.
Transplantation proceedings·2026
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Erratum: Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy.
Translational cancer research·2026
The expert consensus document on minimally invasive upper lobectomy for lung cancer in China.
Journal of thoracic disease·2026